LIVE MARKET TRACKER :   BSE SENSEX   33317.64      |    NSE NIFTY 10270.70    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Mutual Funds  :  Reliance Mutual Fund introduces Capital Builder Fund IV-Series A

Reliance Mutual Fund introduces Capital Builder Fund IV-Series A (29-Sep-2017)

Reliance Mutual Fund has launched the Reliance Capital Builder Fund IV-Series A, a close ended growth scheme. The NFO opens for subscription on September 29, 2017 and closes on October 13, 2017. No entry load and exit load will be applicable for the scheme. The minimum subscription amount is Rs 5,000 and in multiples of Re 1 thereafter.

The scheme's performance will be benchmarked against S&P BSE 200 Index and its fund managers are Meenakshi Dawar, and Jahnvee Shah.

The investment objective of the scheme is to provide capital appreciation to the investors, which will be in line with their long term savings goal, by investing in a diversified portfolio of equity & equity related instruments with small exposure to fixed income securities.


Top News Today
Adlabs Entertainment in talks with three PE firms to raise Rs 650 crore: Report
(13-Dec-2017)

Adlabs Entertainment in talks with three PE firms to raise Rs 650 crore: ReportAdlabs Entertainment is reportedly in talks with three private equity (PE) firms, including Blackstone Group Warburg Pincus and TPG to raise about Rs 650 crore from financial investors as part of a two-pronged......click on news to read complete article.

Kridhan Infra inks SSA to increase stake in VNC
(13-Dec-2017)

Kridhan Infra inks SSA to increase stake in VNCKridhan Infra (KIL) has signed a Share Subscription Agreement (SSA) to significantly enhance its strategic stake in Vijay Nirman Company (VNC). Post the completion of the transaction, VNC will operate......click on news to read complete article.

Alembic Pharma gets USFDA's nod for Darifenacin Extended Tablets
(12-Dec-2017)

Alembic Pharma gets USFDAAlembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Darifenacin Extended-Release Tablets, 7.5 mg and 15......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Mutual Funds News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.